Nick Lynch of the Pistoia Alliance on AI as a Strategic Focus
On this episode, I speak with Nick Lynch of the Pistoia Alliance ( www.pistoiaalliance.org ), a global nonprofit community of life science stakeholders that works to lower barriers to R&D innovation. ...
7 Aug 201832min
Lucas Siow of ProteinQure on AI for Protein-Based Drugs
On this episode, I speak with Lucas Siow, Head of Business Operations at ProteinQure ( www.proteinqure.com ). ProteinQure uses artificial intelligence and quantum computing to design protein-based dru...
7 Aug 201833min
Regina Barzilay, AI Small Molecule Discovery and Synthesis
On this episode, I speak with Regina Barzilay of MIT's Machine Learning for Pharmaceutical Discovery and Synthesis consortium ( http://mlpds.mit.edu ). Regina is a prolific researcher with many highly...
30 Juli 201828min
Tim Guilliams and David Brown, Healx, AI for Rare Diseases
On this episode, I speak with Tim Guilliams and David Brown of Healx. Healx uses AI to repurpose existing drugs for rare diseases. They claim their approach can bring new treatments to patients 80% fa...
26 Juli 201837min
Kristen Fortney, CEO of BioAge Labs, on AI Aging Research
On this episode, I speak with Kristen Fortney, founder and CEO of BioAge Labs ( www.bioagelabs.com ). Kristen leads one of just a few companies focused explicitly on aging itself, rather than the dise...
10 Juli 201825min
Sam Cooper, CEO of Phenomic AI, on Automated HCS and More
On this episode, I speak with Sam Cooper, cofounder and CEO of Phenomic AI ( www.phenomic.ai ). Sam and his team use machine learning for automated image analysis to study cell biology and screen drug...
28 Juni 201823min
Shai Shen-Orr, Chief Scientist, CytoReason, AI in Immunology
On this episode, I speak with Shai Shen-Orr, cofounder and chief scientist of CytoReason ( www.cytoreason.com ). CytoReason has created a machine learning model of the immune system. This model can in...
20 Juni 201831min
